A major breakthrough in cancer study is occurring with the use of VHH fragments to reactivate damaged p53. This essential tumor inhibitor protein is frequently inactivated in many kinds of malignancies, resulting https://mysterybookmarks.com/story21886447/mini-antibodies-revive-p53-new-promising-approach-for-malignant-management